Skip to content

A double-blind randomized controlled trial study on the improvement effect of acupoint embedding on the central distribution of body fat in women during perimenopause

A double-blind randomized controlled trial study on the improvement effect of acupoint embedding on the central distribution of body fat in women during perimenopause

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001080
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal central obesity

Interventions

True buried thread treatment group:catgut implantation at acupoint
Fake buried thread and real needle group:Fake buried thread real needle puncture

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 118/10000 118/100001) 2)=40=603)=75cm//=0.45/=0.784)35) 1) Meet the diagnostic criteria of traditional Chinese and Western medicine for women with heart type body fat distribution during perimenopause; 2) Age = 40 to = 60 years old; 3) Waist circumference = 75cm and/or waist circumference/height = 0.45 and/or waist to hip ratio = 0.78; 4) Patients who have not undergone weight loss within 3 months; 5) Sign the informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1) Individuals under 40 or over 60 years old; 2) Secondary obesity: hypothalamic syndrome pituitary adenoma Cushing's syndrome hypothyroidism insulinoma polycystic ovary syndrome; 3) Uterine or ovarian malformations or after hysterectomy or oophorectomy as well as during pregnancy or lactation; 4) Patients with hyperthyroidism diabetes malignant tumor heart liver kidney hematopoietic system and psychosis; 5) Poor compliance and other situations that are not suitable for meridian therapy.

Design outcomes

Primary

MeasureTime frame
Estradiol;triglyceride;Fasting blood insulin;cholesterol;high density lipoprotein;Fasting blood glucose;testosterone;free testosterone;Testosterone/estradiol levels;Adiponectin;low density lipoprotein;

Secondary

MeasureTime frame
body mass index;waist to hip ratio;Waist height ratio;waist circumference;weight;Body Fat;

Countries

China

Contacts

Public ContactLin Yufang

Zhejiang Hospital

314450783@qq.com17816855809

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026